Target intelligence / Profile preview

Nematode nicotinic acetylcholine receptor like-23 (ACR-23)

Target
ACR-23
Molecular classification
Ion channel, Ligand-gated ion channel, Cys-loop receptor, Nicotinic acetylcholine receptor subfamily
01

Overview

The **nematode nicotinic acetylcholine receptor like-23 (ACR-23)** is a homopentameric ligand-gated cation channel found in nematodes, most studied in *Caenorhabditis elegans*[1][5]. It belongs to the Cys-loop family of ligand-gated ion channels and is structurally homologous to mammalian α7 nicotinic acetylcholine receptors, although it is nematode-specific and has significant differences in ligand specificity[1][3]. ACR-23 functions primarily as a betaine-gated channel with key roles in maintaining normal locomotion in nematodes[3]. The anthelmintic drug monepantel, from the amino-acetonitrile derivative (AAD) class, exerts its effects by acting as a positive allosteric modulator of ACR-23, causing prolonged activation, hypercontraction of body wall muscles, and death of the worm[1][3][5]. Loss-of-function mutations in acr-23 confer resistance to monepantel, making it a major marker for drug efficacy and resistance surveillance[5]. ACR-23 is a validated therapeutic target for nematode control and is highly selective for nematode channels, minimizing safety concerns for use in agriculture and veterinary medicine[1][5].

Other names
ACR-23acetylcholine receptor like-23betaine receptor (context-dependent)monepantel receptor (context-dependent)
02

Mechanism of action

Positive allosteric modulation (monepantel induces channel opening); Agonist activation (betaine acts as endogenous agonist; monepantel acts as modulator and indirect agonist); Overactivation leads to hypercontraction and nematode paralysis and death

03

Biological functions

Signal transductionNeuromuscular controlLocomotion regulationMuscle contraction regulation
04

Disease associations

Infection (nematode parasite survival and motility)Other (therapeutic target for anthelmintic resistance in nematode control)
05

Safety considerations

Species specificity (target is nematode-specific, reducing risk to non-target hosts)Resistance (mutations in acr-23 gene cause resistance to monepantel)
06

Interacting drugs

Monepantel

3 more in the full profile.

07

Biomarkers

acr-23 gene mutation status (for resistance to monepantel therapy in C. elegans and related nematodes)

Beyond the preview

Go deeper on Nematode nicotinic acetylcholine receptor like-23 (ACR-23).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nematode nicotinic acetylcholine receptor like-23 (ACR-23).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call